Immunome
IMNM
$13.83
Share price
-3.96%
Change (1 day)
143.92%
Change (1 year)
Categories
Immunome (IMNM) - Net assets
Net assets on the balance sheet as of December 2023 : $0.11 B
According to Immunome's latest financial reports the company has $0.11 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Immunome - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $16.65 M | -65.44% |
| 2021-12-31 | $48.18 M | 16.54% |
| 2020-12-31 | $41.34 M | -216.04% |
| 2019-12-31 | $-35.63 M | 41.36% |
| 2018-12-31 | $-25.21 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 86.92% | 🇺🇸 USA |